KCNA3 and psoriasis: As the sea anemone toxin analogue ShK-186 recently showed efficacy in a clinical trial on psoriasis, Iontas incorporated several Kv1.3-targeting toxins into the knot body template, yielding potent and selective Kv1.3 blockers capable of reducing T cell cytokine release.